In this study we analyse the trends in new diagnoses for acute and chronic HBV and HCV in the Public Health Service (PHS) region of Amsterdam. In addition, we provide an overview of recent migration patterns and testing provision in the PHS region…
ID
Source
Brief title
Condition
- Viral infectious disorders
Synonym
Research involving
Sponsors and support
Intervention
- Other intervention
N.a.
Outcome measures
Primary outcome
<p>Positive test for Hepatitis B or Hepatitis C</p>
Secondary outcome
<p>N.A.</p>
Background summary
The Netherlands is a low-endemic country for hepatitis B virus (HBV) and hepatitis C virus (HCV), with national estimates of 0.4% for chronic HBV and 0.2% for chronic HCV. There are groups in which HBV and HCV occur more frequently due to the level of risk behavior and/or risk factors, including sexual behavior or because they originate from a high-endemic country for HBV or HCV. The World Health Organization has set the goal of reducing the number of new HBV and HCV infections by 90 percent and the mortality from these diseases by 65 percent by 2030. Progress is being made, also in the Netherlands, but it is expected that too many people will remain undiagnosed. In addition, the progress of actions to prevent HBV and HCV is under pressure due to dynamic populations and declining political support. The GGDs have limited resources for HBV and HCV prevention actions, and it is unclear which migrant groups should be reached for screening and HBV vaccination. Therefore, to make future actions more selective and efficient, it is necessary to gain more insight into which migrant groups (and with which demographic characteristics) have an increased risk of HBV and HCV, and whether the trends of the notifications show correlations with migration patterns. These insights help the infectious disease teams to develop preventive actions among migrant groups in a more targeted manner.
Study objective
In this study we analyse the trends in new diagnoses for acute and chronic HBV and HCV in the Public Health Service (PHS) region of Amsterdam. In addition, we provide an overview of recent migration patterns and testing provision in the PHS region of Amsterdam, to potentially support the interpretation of trends and for action perspectives regarding future interventions
Study design
This is a retrospective quantitative study with an analysis of existing surveillance data, using:
1. Surveillance data from the registration system of the GGD Amsterdam (GLIMS) on HBV and HCV reports and data from the source and contact investigation (BCO)
2. Data from the Central Bureau of Statistics (CBS) on population numbers
3. Data from Aphrodite (surveillance system of the Centre for Sexual Health) on the number of test requests, and other overviews on the additional test offer (‘outreach’ and other initiatives) in the Amsterdam region
Intervention
N.A.
Study burden and risks
Low, this is a retrospective study. We conducted a Data Protection Impact Assessment.
E Generaal
Nieuwe Achtergracht 100
Amsterdam 1018 WT
Netherlands
020 555 5043
egeneraal@ggd.amsterdam.nl
E Generaal
Nieuwe Achtergracht 100
Amsterdam 1018 WT
Netherlands
020 555 5043
egeneraal@ggd.amsterdam.nl
Listed location countries
Age
Inclusion criteria
Notification of positive test with Hepatitis B or Hepatitis C at the Public Health Service of Amsterdam
Exclusion criteria
N.A.
Design
Recruitment
Medical products/devices used
IPD sharing statement
Plan description
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
Research portal | NL-009808 |